Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function

Documenti analoghi

• Equivalent benefit of mTORC1 blockade and combined PI3K-mTOR blockade in a mouse model of tuberous sclerosis
  di: Pollizzi, Kristen, et al.
  Pubblicazione: (2009)
• Tuberous Sclerosis Complex Activity Is Required to Control Neuronal Stress Responses in an mTOR-Dependent Manner
  di: Di Nardo, Alessia, et al.
  Pubblicazione: (2009)
• The mammalian Target of Rapamycin (mTOR) regulates T helper cell differentiation through the selective activation of mTORC1 and mTORC2 signaling
  di: Delgoffe, Greg M., et al.
  Pubblicazione: (2011)
• Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
  di: Feldman, Morris E, et al.
  Pubblicazione: (2009)
• Mammalian Target of Rapamycin Complex 1 (mTORC1) Activity Is Associated with Phosphorylation of Raptor by mTOR
  di: Wang, Lifu, et al.
  Pubblicazione: (2009)